Zynyz to treat Merkel cell carcinoma
Drug Name: Zynyz Indications: To treat metastatic or recurrent locally advanced Merkel cell carcinoma. Active Ingredient: Retifanlimab-dlwr Company: Incyte Corporation Approval Date: 3/22/2023 More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761334s000lbl.pdf